Hong Kong · Delayed Price · Currency is HKD Frontage Holdings Company Description
Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.
It offers drug discovery services comprising medicinal chemistry, pharmacology, and efficacy, as well as absorption, distribution, metabolism, and excretion (ADME) screening.
The company also provides drug metabolism and pharmacokinetics (DMPK); safety and toxicology; early phase clinical services; and bioequivalence and related services, such as pharmacology, medical writing, and regulatory support.
In addition, it offers pharmaceutical product development services, including intermediate and active pharmaceutical ingredient (API) synthesis, process and formulation development, and clinical trial material manufacturing.
Further, the company provides laboratory testing services, such as bioanalysis, biomarkers, genomics, CMC Analytical testing, and central laboratory services.
It operates in the United States, Canada, the People’s Republic of China, Europe, India, Japan, South Korea, and Australia.
The company was incorporated in 2018 and is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation operates as a subsidiary of Hongkong Tigermed Co., Limited.
| Country | Cayman Islands |
| Founded | 2018 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,560 |
| CEO | Abdul Mutlib |
Contact Details
Address: 700 Pennsylvania Drive Exton, 19341 United States | |
| Phone | 610 232 0100 |
| Website | frontagelab.com |
Stock Details
| Ticker Symbol | 1521 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | KYG3679P1019 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Dr. Wentao Zhang Ph.D. | Co-Chief Executive Officer and Executive Director |
| Dr. Zhongping Lin Ph.D. | Co-Chief Executive Officer Executive and Director |
| Dr. Song Li Ph.D. | Founder and Chairman |
| Dr. Abdul Ezaz Mutlib Ph.D. | Chief Scientific and Strategy Officer and President of Frontage Laboratories of Canada |
| Huan Wang | Interim Chief Financial Officer |
| Richard Fischetti J.D. | Vice President and General Counsel of Frontage Labs |
| Dr. Dongmei Wang Ph.D. | Executive Vice President of Global Sales and Marketing and Project Management |
| Dr. Tianyi Zhang | Senior Vice President of the Group and GM of Frontage Shanghai |
| Sudendra Rao Ph.D. | Senior Vice President of Human Resources - North America |
| Dr. John Kapeghian Ph.D. | Executive Vice President of Global Safety and Toxicology |